COVID-19 vaccination in Africa
COVID-19 vaccination programs have begun in many countries and territories in Africa.
 Vial of the Janssen COVID-19 vaccine used in South Africa | |
| Date | 2021 |
|---|---|
| Cause | COVID-19 pandemic in Africa |
Cumulative People Fully Vaccinated in Africa
Vaccination by territory[edit]
Algeria[edit]
Algeria launched a coronavirus vaccination campaign on 29 January 2021, a day after receiving its first shipment of 50,000 doses of the Russia’s Sputnik V vaccine.[1]
Angola[edit]
Covid-19 vaccination has not begun in Angola, but they have received 624,000 doses of Oxford AstraZeneca vaccine[2]
Benin[edit]
Covid-19 vaccination has not begun in Benin
Botswana[edit]
Covid-19 vaccination has not begun in Botswana
Burkina Faso[edit]
Covid-19 vaccination has not begun in Burkina Faso
Burundi[edit]
Covid-19 vaccination has not begun in Burundi
Cape Verde[edit]
Covid-19 vaccination has not begun in Cape Verde
Cameroon[edit]
Covid-19 vaccination has not begun in Cameroon
Central African Republic[edit]
Covid-19 vaccination has not begun in Central African Republic
Chad[edit]
Covid-19 vaccination has not begun in Chad
Comoros[edit]
Covid-19 vaccination has not begun in Comoros
Democratic Republic of the Congo[edit]
Covid-19 vaccination has not begun in Democratic Republic of the Congo
Republic of the Congo[edit]
Covid-19 vaccination has not begun in Republic of the Congo
Côte d’Ivoire[edit]
Covid-19 vaccination has not begun in Côte d’Ivoire
Djibouti[edit]
Covid-19 vaccination has not begun in Djibouti
Egypt[edit]
Covid-19 vaccination has not begun in Egypt
Equatorial Guinea[edit]
Covid-19 vaccination has not begun in Equatorial Guinea
Eritrea[edit]
Covid-19 vaccination has not begun in Eritrea
Eswatini[edit]
Covid-19 vaccination has not begun in Eswatini
Ethiopia[edit]
Covid-19 vaccination has not begun in Ethiopia
Gabon[edit]
Covid-19 vaccination has not begun in Gabon
Gambia[edit]
Covid-19 vaccination has not begun in Gambia
Ghana[edit]
Ghana launched a coronavirus vaccination program using the Oxford-AstraZeneca vaccine apart of the COVAX initiative on 1 March 2021.
Guinea[edit]
Covid-19 vaccination has not begun in Guinea
Guinea-Bissau[edit]
Covid-19 vaccination has not begun in Guinea-Bissau
Kenya[edit]
Covid-19 vaccination has not begun in Kenya
Lesotho[edit]
Covid-19 vaccination has not begun in Lesotho
Liberia[edit]
Covid-19 vaccination has not begun in Liberia
Libya[edit]
Covid-19 vaccination has not begun in Libya
Madagascar[edit]
Covid-19 vaccination has not begun in Madagascar
Malawi[edit]
Covid-19 vaccination has not begun in Malawi
Mali[edit]
Covid-19 vaccination has not begun in Mali
Mauritania[edit]
Covid-19 vaccination has not begun in Mauritania
Mauritius[edit]
Covid-19 vaccination has not begun in Mauritius
Morocco[edit]
On 28 January 2021, Morocco has started its coronavirus vaccine rollout [3]
Mozambique[edit]
Covid-19 vaccination has not begun in Mozambique
Namibia[edit]
Covid-19 vaccination has not begun in Namibia
Niger[edit]
Covid-19 vaccination has not begun in Niger
Nigeria[edit]
COVID-19 vaccination began in Nigeria on 5 March 2021.[4]
Rwanda[edit]
Covid-19 vaccination has not begun in Rwanda
Sao Tome and Principe[edit]
Covid-19 vaccination has not begun in Sao Tome and Principe
Senegal[edit]
Senegal on 23 February 2021 began its vaccination campaign against the coronavirus with 200,000 doses of Sinopharm vaccines it purchased from China the previous week.[5]
Seychelles[edit]
Covid-19 vaccination has not begun in Seychelles
Sierra Leone[edit]
Covid-19 vaccination has not begun in Sierra Leone
Somalia[edit]
Covid-19 vaccination has not begun in Somalia
South Africa[edit]
On 18 February 2021 South Africa started its national vaccination program against Covid-19. The program will go through in phases, prioritizing healthcare and frontline workers and then those over the age of 65.[6]
Johnson & Johnson COVID-19 vaccine developed by Janssen.jpg
South Sudan[edit]
Covid-19 vaccination has not begun in South Sudan
Sudan[edit]
Covid-19 vaccination has not begun in Sudan
Tanzania[edit]
Covid-19 vaccination has not begun in Tanzania
Togo[edit]
Covid-19 vaccination has not begun in Togo
Tunisia[edit]
Covid-19 vaccination has not begun in Tunisia
Uganda[edit]
Covid-19 vaccination has not begun in Uganda
Zambia[edit]
Covid-19 vaccination has not begun in Zambia
Zimbabwe[edit]
On 22 February 2021, Zimbabwe launched their national Covid-19 vaccination program using the BBIBP-CorV/Sinopharm COVID-19 vaccine. As of 4 March 2021 they have vaccinated 30,658 people.[7][8]
Variants Resistant to Vaccines[edit]
501Y.V2[edit]
The 501Y.V2 variant of the disease is less effective against some of the vaccines.
In January, Johnson & Johnson, which held trials for its Ad26.COV2.S vaccine in South Africa, reported the level of protection against moderate to severe COVID-19 infection was 72% in the United States, but 57% in South Africa.[9]
On 6 February 2021, The Financial Times reported that provisional trial data from a study undertaken by South Africa's University of the Witwatersrand in conjunction with Oxford University demonstrated reduced efficacy of the Oxford–AstraZeneca COVID-19 vaccine against the 501.V2 variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal protection" in all but the most severe cases of COVID-19.[10]
On 7 February 2021, the Minister for Health for South Africa suspended the planned deployment of around 1 million doses of the vaccine whilst they examine the data and await advice on how to proceed.[11]
In February, Moderna reported that the current vaccine produced only one-sixth of the antibodies in response to the South African variant compared with the original virus. They have launched a trial of a new vaccine to tackle the South African 501.V2 variant.[12]
On 17 February 2021, Pfizer announced neutralization activity was reduced by two thirds for the 501.V2 variant, while stating no claims about the efficacy of the vaccine in preventing illness for this variant could yet be made.[13]
Vaccine Effectiveness[edit]
The 501Y.V2 variant of the disease is less effective against some of the vaccines.
In January, Johnson & Johnson, which held trials for its Ad26.COV2.S vaccine in South Africa, reported the level of protection against moderate to severe COVID-19 infection was 72% in the United States, but 57% in South Africa.[14]
On 6 February 2021, The Financial Times reported that provisional trial data from a study undertaken by South Africa's University of the Witwatersrand in conjunction with Oxford University demonstrated reduced efficacy of the Oxford–AstraZeneca COVID-19 vaccine against the 501.V2 variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal protection" in all but the most severe cases of COVID-19.[15]
On 7 February 2021, the Minister for Health for South Africa suspended the planned deployment of around 1 million doses of the vaccine whilst they examine the data and await advice on how to proceed.[16]
In February, Moderna reported that the current vaccine produced only one-sixth of the antibodies in response to the South African variant compared with the original virus. They have launched a trial of a new vaccine to tackle the South African 501.V2 variant.[17]
B.1.1.207[edit]
Vaccination By Territory[edit]
Manufacturing[edit]
Johnson & Johnson[edit]
In a manufacturing deal, Johnson and Johnson’s plan to manufacture 220 Million vaccine at The Aspen Pharmacare manufacturing facility in Gqeberha, Eastern Cape. They plan to distribute the vaccine to other African countries with 30 million to go to South Africa.[19][20][21]
Approval Status[edit]
See also[edit]
References[edit]
- ^ "Algeria launches coronavirus vaccination campaign". SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader. 2021-01-31. Retrieved 2021-03-06.
- ^ AfricaNews (2021-03-03). "Angola begins Covid immunization fight with COVAX vaccines". Africanews. Retrieved 2021-03-08.
- ^ AfricaNews (2021-01-26). "Morocco begins COVID-19 vaccine rollout". Africanews. Retrieved 2021-03-06.
- ^ @UNICEF_Nigeria (March 5, 2021). "History is made! Dr. Cyprian Ngong, a Snr. Registrar at the National Hospital, Abuja is the first person to receive the #COVID19 vaccine in Nigeria. The vaccine was administered by @drfaisalshuaib, ED of @NphcdaNG during the flag-off of the #COVID19 vaccination drive in Abuja" (Tweet). Retrieved 25 April 2021 – via Twitter.
- ^ AfricaNews (2021-02-23). "Senegal begins covid-19 vaccination with doses from China's Sinopharm". Africanews. Retrieved 2021-03-06.
- ^ "SA's COVID-19 Vaccination Rollout Kicks Off In Khayelitsha - SA Corona Virus Online Portal". SA Corona Virus Online Portal. Retrieved 2021-03-06.
- ^ "Zimbabwe starts Covid-19 vaccinations, Vice President Chiwenga gets first shot". News24. Retrieved 2021-03-05.
- ^ "Zimbabwe expected to begin COVID-19 vaccinations on Thursday". SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader. 2021-02-17. Retrieved 2021-03-05.
- ^ "Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial". jnj.com. 29 January 2021. Retrieved 29 January 2021.
- ^ Booth, William; Johnson, Carolyn Y. (7 February 2021). "South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report 'minimal' protection against coronavirus variant". The Washington Post. London. Retrieved 2021-02-08.
South Africa will suspend use of the coronavirus vaccine being developed by Oxford University and AstraZeneca after researchers found it provided "minimal protection" against mild to moderate coronavirus infections caused by the new variant first detected in that country.
- ^ "Covid: South Africa halts AstraZeneca vaccine rollout over new variant". BBC News. 8 February 2021. Retrieved 12 February 2021.
- ^ Kuchler, Hannah (25 January 2021). "Moderna develops new vaccine to tackle mutant Covid strain". Financial Times. Retrieved 30 January 2021.
- ^ Liu, Yang; Liu, Jianying; Xia, Hongjie; Zhang, Xianwen; Fontes-Garfias, Camila R.; Swanson, Kena A.; Cai, Hui; Sarkar, Ritu; Chen, Wei; Cutler, Mark; Cooper, David; Weaver, Scott C.; Muik, Alexander; Sahin, Ugur; Jansen, Kathrin U.; Xie, Xuping; Dormitzer, Philip R.; Shi, Pei-Yong (17 February 2021). "Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report". New England Journal of Medicine. doi:10.1056/nejmc2102017. Retrieved 25 February 2021.
- ^ "Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial". jnj.com. 29 January 2021. Retrieved 29 January 2021.
- ^ Booth, William; Johnson, Carolyn Y. (7 February 2021). "South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report 'minimal' protection against coronavirus variant". The Washington Post. London. Retrieved 2021-02-08.
South Africa will suspend use of the coronavirus vaccine being developed by Oxford University and AstraZeneca after researchers found it provided "minimal protection" against mild to moderate coronavirus infections caused by the new variant first detected in that country.
- ^ "Covid: South Africa halts AstraZeneca vaccine rollout over new variant". BBC News. 8 February 2021. Retrieved 12 February 2021.
- ^ Kuchler, Hannah (25 January 2021). "Moderna develops new vaccine to tackle mutant Covid strain". Financial Times. Retrieved 30 January 2021.
- ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf "Github OWID Covid Vaccinations". Github. Retrieved 17 February 2021.
- ^ "Covid-19: SA plans to vaccinate 200 000 people a day - report". News24. Retrieved 2021-03-31.
- ^ "COVID-19 vaccine: J&J commits 30 million doses for SA | eNCA". www.enca.com. Retrieved 2021-03-31.
- ^ "'No setbacks.' SA factory on track to produce J&J vaccine". BusinessInsider. Retrieved 2021-03-31.
